Intensity Therapeutics, Inc. Announces That Int230-6 Achieved 100% Complete Response Rate In Preclinical Models Of Malignant Peripheral Nerve Sheath Tumors (Mpnst)
Intensity Therapeutics Inc INTS.O:
INTENSITY THERAPEUTICS, INC. ANNOUNCES THAT INT230-6 ACHIEVED 100% COMPLETE RESPONSE RATE IN PRECLINICAL MODELS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
INTENSITY THERAPEUTICS INC - INT230-6 SHOWS COMPLETE RESPONSE IN 21 DAYS IN MPNST STUDY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.